Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/bed0290f-10c3-46eb-9ae3-e4a990955009/

GILD

Gilead Sciences Inc
Chart
$129.16
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.58
OS Score
21.0%
Value
98.0%
Quality
68.0%
Momentum
9/9
F-Score
0.454
QV
Strategy Eligibility
6 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
8.2%
Veiled Value
Yes
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
Noneyr
🌱
GARP
🔄
Shareholder Yield
2.5%
💰
High Yield
🚀
Momentum Leaders
12-1 20%
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
Vol 23%
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
21.0%ile
P/E
17.6×
P/S
5.4×
P/B
6.9×
E/P
0.0569
FCF Yield
0.064
EBITDA/EV
0.082
SH Yield
0.025
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
83.00000000
/100 — 1=cheapest
VC2 (Trending Value)
77.00000000
/100
VC3 (Buyback)
77.00000000
/100
FCF yield of 6.4% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
98.0%ile
ROE
0.392
ROA
0.164
Net Margin
0.310
Op Margin
0.395
GPA
0.419
D/E
1.40
Current
1.97
F-Score
9/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.035
Earn Growth
0.545
Stability
0.301
lower=better
Accruals
-0.028
lower=better
5yr Consist
Yes
ROE of 39% is exceptional. F-Score of 9/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
68.0%ile
6M Return
7.9%
12M Return
17.9%
12-1 Mom
19.9%
Risk-Adj
0.86
Vol 252d
23.2%
Vol 60d
52.3%
↑ Expanding
Max DD 12M
-16.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (52%) is expanding vs long-term (23%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.58
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
6.2%
Sector Quality %ile
99.8%
P/E z-score
-0.14
P/B z-score
0.16
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Quality at a Premium
High quality (98th) but expensive (21th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (52%) significantly exceeds 252-day (23%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
47.1% avg (7 factors)
Quality
A
82.6% avg (8 factors)
Momentum
C
51.7% avg (4 factors)
Risk
A
77.9% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.580—0
Value %ile0.210—1
Quality %ile0.980—1
Momentum %ile0.680—0
F-Score9.000—1
Confidence0.970—1
Volatility0.232—0
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
17.57
Earnings Yield (E/P)
0.0569
Price / Sales
5.45
Price / Book
6.89
Price / Cash Flow
14.99
FCF Yield
6.4%
EBITDA / EV
8.2%
Sales Yield (1/P·S)
0.1685
Shareholder Yield
Div + net buyback / mktcap
2.5%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
39.2%
Return on Assets
16.4%
Net Margin
31.0%
Operating Margin
39.5%
Gross Profit / Assets
Novy-Marx GPA
41.9%
Debt / Equity
1.40
Current Ratio
1.97
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.028
MomentumPrice trend strength over different horizons
6M Return
7.9%
12M Return
17.9%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
19.9%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.86
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
3.5%
Earnings Growth (YoY)
54.5%
Earnings Stability (CV)
Lower = more stable
0.301
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
9
Dividend Yield
2.5%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
83
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
77
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
77
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
Yes
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity